Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Paracetamol IV Market Research Report by Indication (Pain and Pyrexia/Fever), Application, End-use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Paracetamol IV Market size was estimated at USD 878.46 million in 2022, USD 940.79 million in 2023, and is projected to grow at a CAGR of 7.57% to reach USD 1,575.45 million by 2030.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.
Market Segmentation & Coverage:
The report on the Global Paracetamol IV Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making.
The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience.
This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan.
This research report categorizes the Global Paracetamol IV Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Indication, the market is studied across Pain and Pyrexia/Fever.
- Based on Application, the market is studied across Non-surgical and Surgical.
- Based on End-use, the market is studied across Clinics and Hospitals.
- Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Paracetamol IV Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Paracetamol IV Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Paracetamol IV Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Paracetamol IV Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Paracetamol IV Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Paracetamol IV Market?
4. What is the competitive strategic window for opportunities in the Global Paracetamol IV Market?
5. What are the technology trends and regulatory frameworks in the Global Paracetamol IV Market?
6. What is the market share of the leading vendors in the Global Paracetamol IV Market?
7. What modes and strategic moves are considered suitable for entering the Global Paracetamol IV Market?
Report Metrics
| Report Attribute | Details |
| No. of Pages | 230 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $878.46 Million |
| Forecasted Market Value (USD) by 2030 | $1575.45 Million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Growing prevalence of indicative diseases and conditions
- Increasing use of paracetamol IV in relieving fever in post-surgical procedures
- Enhanced usage of acetaminophen to reduce the dependence on opioids for pain management
Restraints
- Availability of multiple generic products
Opportunities
- Government initiatives and rising research and development activities
- Use of paracetamol IV in combination with non-steroidal anti-inflammatory drugs (NSAID) and narcotics
Challenges
- Lack of experienced healthcare professionals
Companies Mentioned
- Aurobindo Pharma Ltd.
- Biological E. Limited
- Cfl Pharmaceuticals Limited
- Changshu Huagang Pharmaceuticals Co., Ltd.
- Dr. Reddy's Laboratories Ltd.
- Geno Pharmaceuticals Private Limited
- Hebei Jiheng Pharmaceutical Co.,Ltd.
- Huzhou Konch Pharmaceutical Co., Ltd.
- Lupin Pharmaceuticals, Inc.
- Mallinckrodt PLC
- Novartis AG
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
- Zhejiang Kangle Pharmaceutical Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/7zl5h2-iv?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
